I have spent my career at Memorial Sloan Kettering as a breast imaging radiologist where I interpret digital mammography including tomosynthesis, breast ultrasound, and breast MRI and perform breast biopsies under imaging guidance. Currently I serve as Chief of the Breast Imaging Service and am responsible for the clinical, teaching and research breast imaging program at all Memorial Sloan Kettering sites.
At Memorial Sloan Kettering we screen for breast cancer at all risk levels. Screening for breast cancer when the lesion is small and treatable can save a woman’s life which is why I am strongly drawn to the field of breast imaging. We have pioneered high risk screening with MRI and offer screening with MRI, ultrasound, contrast enhanced digital mammography, and tomosynthesis.
My research focus is on how best to use newer techniques such as MRI for early breast cancer detection and to improve the workup of breast lesions. In collaboration with my colleagues, I have written many papers, chapters, and books about breast disease with an emphasis on the use of MRI. We have published studies on the use of MRI for staging breast cancer and for screening women at high risk for cancer.
I am a Professor of Radiology at Weill Cornell Medical College. I was elected a Fellow of the Society of Breast Imaging and of the American College of Radiology (ACR). I serve as Chair of the ACR MRI BI-RADS Lexicon committee and Vice President of the Society of Breast Imaging. These groups work to ensure that women throughout the country receive high-quality breast-imaging care. I lecture and teach breast imaging radiologists widely, both nationally and internationally, on breast imaging and biopsy techniques.
- Clinical Expertise: Breast Imaging (MRI, Digital Mammography, Ultrasound)
- Languages Spoken: English
- Education: MD, University of California, San Francisco, School of Medicine
- Residencies: The New York Hospital/Cornell Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Radiology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more